Simeng Hu
Impact in
-
- Immune cells in cancer
Papers in
-
- Angiogenesis and VEGF in Cancer 1
- Epigenetics and DNA Methylation 1
- FOXO transcription factor regulation 1
- Oncology 3
- Co-authors
- Fan Bai (4 shared papers)Xudong Xing (2 shared papers)Wenxiao Dai (1 shared paper)Huanzi Lu (1 shared paper)Zhongyan Shan (1 shared paper)Xinyu Guo (1 shared paper)Juan Fang (1 shared paper)Qianming Chen (1 shared paper)
- Journals
- Bioinformatics (1 paper)Clinical and Translational Medicine (1 paper)European Heart Journal (1 paper)Journal of Clinical Investigation (1 paper)Frontiers in Neuroscience (1 paper)
- Partner nations
- ChinaUnited KingdomGermany
In The Last Decade
Simeng Hu
13 papers receiving 154 citations
Peers
Comparison fields: 5 of 52
- Biological Psychiatry 6
- Immunology 31
- Dermatology 12
- Cancer Research 18
- Oncology 32
Countries citing papers authored by Simeng Hu
This map shows the geographic impact of Simeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simeng Hu more than expected).
Fields of papers citing papers by Simeng Hu
This network shows the impact of papers produced by Simeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simeng Hu. The network helps show where Simeng Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Simeng Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 68 | |
| 2 | 2023 | 20 | |
| 3 | 2018 | 18 | |
| 4 | 2024 | 16 | |
| 5 | 2022 | 13 | |
| 6 | 2024 | 6 | |
| 7 | 2019 | 6 | |
| 8 | 2017 | 3 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 1 | |
| 11 | Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). | 2015 | 1 |
| 12 | 2022 | 1 | |
| 13 | Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. | 2015 | 1 |
| 14 | 2024 | 0 |
About Simeng Hu
Simeng Hu is a scholar working on Molecular Biology, Oncology, Dermatology, Immunology and Pathology and Forensic Medicine, having authored 14 papers that have together received 155 indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Epigenetics and DNA Methylation (1 paper), Vaccine Coverage and Hesitancy (1 paper), MRI in cancer diagnosis (1 paper), FOXO transcription factor regulation (1 paper), Ammonia Synthesis and Nitrogen Reduction (1 paper) and Catalytic Processes in Materials Science (1 paper). The work is most often cited by research in Biological Psychiatry (6 citations), Immunology (31 citations), Dermatology (12 citations), Cancer Research (18 citations) and Oncology (32 citations). Simeng Hu has collaborated with scholars based in China, United Kingdom and Germany. Frequent co-authors include Fan Bai, Xudong Xing, Wenxiao Dai, Huanzi Lu, Zhongyan Shan, Xinyu Guo, Juan Fang, Qianming Chen, Dikan Wang and Yanshu Zhang. Their work appears in journals such as Bioinformatics, Clinical and Translational Medicine, European Heart Journal, Journal of Clinical Investigation and Frontiers in Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.